Pennant Group
PNTG · NASDAQ
About PNTG
- Employees
- 9,700
- Headquarters
- Eagle, Idaho
- Listed
- Sep 19, 2019
- Sector
- Health Care
- Industry
- Health Care Providers & Services
- Website
- pennantgroup.com
PNTG key statistics
- Market cap
- 1.45B
- Price-earnings ratio
- 44.68
- Dividend yield
- —
- Average volume
- 310.52K
- Volume
- 287.12K
- Open price
- $40.78
- High today
- $41.88
- Low today
- $40.78
- 52 Week high
- $42.74
- 52 Week low
- $22.26
Pennant Group (PNTG) at a glance
Pennant Group (PNTG) last traded at $41.48, with a market cap of 1.45B and a price-to-earnings ratio of 44.68.
Today the stock has traded between $40.78 and $41.88. The current price is 1.7% above the day's low and 1.0% below its high.
Volume so far is 287.12K shares, in line with the average of 310.52K shares a day.
Over the past year Pennant Group has ranged from $22.26 to $42.74, and now sits 94% of the way up that range.
Pennant Group met or beat analyst EPS estimates in 6 of the last 8 quarters. In Q2 FY26 it reported $0.36 per share against an estimate of $0.3366.
The average analyst price target is $47.60, 14.8% above the current price, from 5 recent ratings.
Analyst ratings
Latest rating from each analyst over the past 12 months
- Buy100.0%
- Hold0.0%
- Sell0.0%
- Low
- $44.44
- Now
- $41.48
- High
- $51.45
PNTG earnings
Earnings per share, reported against the analyst estimate
Beat the estimate in 6 of the last 8 quarters, by 7.0% on average.
- Q3 FY24: reported $0.26 per share against an estimate of $0.2346
- Q4 FY24: reported $0.24 per share against an estimate of $0.2448
- Q1 FY25: reported $0.27 per share against an estimate of $0.2423
- Q2 FY25: reported $0.27 per share against an estimate of $0.2754
- Q3 FY25: reported $0.30 per share against an estimate of $0.2839
- Q4 FY25: reported $0.34 per share against an estimate of $0.322
- Q1 FY26: reported $0.32 per share against an estimate of $0.3147
- Q2 FY26: reported $0.36 per share against an estimate of $0.3366
PNTG news
A Glimpse Into The Expert Outlook On Pennant Gr Through 4 Analysts
Forecasting The Future: 4 Analyst Projections For Pennant Gr
Breaking Down Pennant Gr: 4 Analysts Share Their Views
What Analysts Are Saying About Pennant Gr Stock
- Press releaseBusiness Wire
CareTrust REIT Positions for Continued Growth with New $500 Million Term Loan and New Hires
A Glimpse Into The Expert Outlook On Pennant Gr Through 4 Analysts
Assessing Pennant Gr: Insights From 6 Financial Analysts
Similar companies
Companies in the same industry as Pennant Group
Most active stocks
Highest trading volume today
- EARIEntertainment Arts Research$0.0003−16.67%
- SEIISharing Economy International$0.0004+100.00%
- NWGLCL Workshop Group$0.1522+27.90%
- TMSHTrans Global Assets$0.0002+0.00%
- AEFIAmerican EcoFuels$0.0007+0.00%
- CBDW1606$0.0002+0.00%
- FITYFifty 1 Labs$0.0001−66.67%
- PRSOPeraso$0.5914+54.13%
- SDSTStardust Power$0.02−23.66%
- SHFSSHF Holdings$0.0899−4.36%
- FRTTFort Technology$0.7121+32.63%
- CBDLCBD Life Sciences$0.0002−25.00%
Newly listed
Companies that went public in the past six weeks
- TCXBTCGX Acquisition Corp. II$10.56+1.54%
- CTYCITY THERAPEUTICS$20.83−2.94%
- IAMIambic Therapeutics$16.01−2.02%
- AMROAmaero$5.68+1.25%
- FLSCFrazier Life Sciences Acquisition Corp. II$10.28−0.10%
- TRXBTRex Bio$14.44−2.43%
- RTSNRetension Pharmaceuticals$16.18−0.92%
- PAXGUPine Tree Acquisition$9.98+0.00%
- PORTUSouthport Acquisition Corp. IIListed Oct 1, 2026
- CHWMChilwa Minerals$5.18+3.39%
- ACCVAccelevation Holdings$12.31−1.44%
- RZAIROZE AI$10.28+1.28%
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.